News mentioning $RARE
836 stories
Jul 29, 26FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute
Jul 29, 26Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
Jul 29, 26Capricor and Replimune prep for FDA adcomms, Q2 earnings roll on, Sarepta’s new leader, more
Jul 28, 26STAT+: Bracing for another Fauci hearing
Jul 28, 26STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
Jul 27, 26STAT+: Pharma’s drug spending deflection